# Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma

> **NCT00816855** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 52 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** docetaxel, cisplatin, fluorouracil

## Key facts

- **NCT ID:** NCT00816855
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-02
- **Primary completion:** 2009-12
- **Final completion:** 2010-06
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2009-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00816855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00816855, "Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00816855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*